📰 Priority Review News
Page 95 - Priority Review News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Priority Review. Real-time updates on events, politics, business and more.
August 31, 2022
SP-103 receives Fast Track Designation, which makes it eligible for some or all of the following: More frequent meetings or written communication with the...
August 31, 2022
XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations) Paris, August 31, 2022. The U.S. Food and Drug Administration (FDA) has
August 31, 2022
Investegate announcements from Sanofi - Aventis Groupe, Press Release: XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)
August 30, 2022
TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) — Theralase
August 27, 2022
SUZHOU, China and ROCKVILLE, Md. , Aug. 26, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis
August 26, 2022
-This marks the second indication for Pemazyre, which received accelerated FDA approval in 2020 for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with
August 26, 2022
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
August 24, 2022
The FDA has accepted for Priority Review the sNDA for olaparib in combination with abiraterone or prednisolone for adults with mCRPC.
August 23, 2022
Commentary The U.S. Food and Drug Administration (FDA) has a legal obligation to protect the public and ensure that the ...
August 23, 2022
KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK) Tuesday said that the Food and Drug Administration (FDA) granted Fast Track designation for its investigational anticoagulant therapy MK-2060 for